Log In
Print this Print this

Intranasal oxytocin (OPN-300)

  Manage Alerts
Collapse Summary General Information
Company OptiNose Inc.
DescriptionIntranasal oxytocin delivered using the OptiNose bidirectional nasal delivery device
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase II
Standard IndicationAutism
Indication DetailsTreat autism spectrum disorder (ASD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today